Novo Nordisk Foundation grants $17m for pharma fermentation pilot plant

By Gareth Macdonald contact

- Last updated on GMT

iStock/angelp
iStock/angelp

Related tags: Bacteria, Biotechnology, Copenhagen

The Novo Nordisk Foundation has awarded a DKK118m ($17m) grant to fund development of a fermentation pilot plant for cell line scale up experiments at the Technical University of Denmark.

The plant is intended to support development of so called “cell factories,” which are bacteria, yeast and mammalian cells modified to produce drugs or chemicals used their production.

A University spokeswoman told us “The plant will be located in the headquarters of The Novo Nordisk Foundation Center for Biosustainability – DTU Biosustain – that is at Technical University of Denmark in Kongens Lyngby​.”

She added that: “We expect the plant to be fully operational by May or June this year​.”

Scale-up

The facility will allow researchers to test how the cell lines are impacted by industry relevant parameters like temperature, pressure and oxygenation according to Bernhard Palsson, CEO of the Novo Nordisk Foundation Centre for Biosustainability.

Developing a cell line that is very productive in small trials does not guarantee that the cells will produce efficiently in the large bioreactors used by industry.

Palsson added that: “The new plant can give a more realistic idea of the potential and the costs associated with specific types of products​.”

Funding

The Novo Nordisk Foundation Centre for Biosustainability was established at the Technical University of Denmark in 2011 with the support of a grant from the Novo Nordisk Foundation.

A spokesman told us the foundation “supports free and independent research at public research institutions and any research result belongs to the researchers and their institutions​.”

Related news

Show more

Related products

show more

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Follow us

Products

View more

Webinars